XDR-TB Transmitted from Mother to 10-Month-Old Infant: Diagnostic and Therapeutic Problems

XDR-TB Transmitted from Mother to 10-Month-Old Infant: Diagnostic and Therapeutic Problems

Drug-resistant TB (DR-TB) in children is a special epidemiological, clinical, and diagnostic problem, and its global incidence remains unknown. DR-TB in children is usually of a primary nature and is most often transmitted to the child from a household contact, so these cases reflect the prevalence...

Full description

Bibliographic Details
Main Authors:	Monika Kozińska, Krystyna Bogucka, Krzysztof Kędziora, Jolanta Szpak-Szpakowska, Wiesława Pędzierska-Olizarowicz, Andrzej Pustkowski, Ewa Augustynowicz-Kopeć
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Diagnostics
Subjects:	<i>Mycobacterium tuberculosis</i> drug resistance XDR-tuberculosis household TB transmission
Online Access:	https://www.mdpi.com/2075-4418/12/2/438

Similar Items

Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report
by: Nafiseh Izadi, et al.
Published: (2015-01-01)

Tuberculosis extremadamente resistente (TB-XDR), historia y situación actual
by: Alberto Mendoza Ticona, et al.
Published: (2018-06-01)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of <i>Mycobacterium tuberculosis</i>
by: María Alejandrina Martínez-González, et al.
Published: (2021-12-01)

Multidrug-Resistant Tuberculosis—Diagnostic Procedures and Treatment of Two Beijing-like TB Cases
by: Monika Kozińska, et al.
Published: (2022-07-01)

Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022-01-01)

The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis
by: Heidary M, et al.
Published: (2019-11-01)

Pre-XDR spinal tuberculosis and 360° approach in two surgical times: a case report
by: C. Montero-Silva, et al.
Published: (2023-01-01)

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
by: Ketaki V Utpat, et al.
Published: (2023-01-01)

Cutaneous and Pulmonary Tuberculosis—Diagnostic and Therapeutic Difficulties in a Patient with Autoimmunity
by: Monika Kozińska, et al.
Published: (2023-02-01)

Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94–32 central Asian/Russian clusters
by: B. J. Klotoe, et al.
Published: (2019-06-01)

Extensively drug-resistant tuberculosis: a case report and literature review
by: João Alves de Araújo-Filho, et al.

Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis
by: Giovanni Sotgiu, et al.
Published: (2013-01-01)

Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases
by: Isaac Darko Otchere, et al.
Published: (2023-01-01)

Risk Factors for Poor Outcomes Among Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB): A Scoping Review
by: Varshney K, et al.
Published: (2021-12-01)

Investigation of Susceptibility of Mycobacterium tuberculosis Complex Strains Isolated from Clinical Samples Against the First and Second-Line Anti-tuberculosis Drugs by the Sensititre MycoTB Plate Method
by: Figen KAYSERİLİ ORHAN, et al.
Published: (2018-03-01)

On the onset and dispersal of a major MDR TB clone among HIV-negative patients, Tunisia
by: Naira Dekhil, et al.
Published: (2024-02-01)

Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition
by: Cong Yao, et al.
Published: (2021-08-01)

Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
by: Mahdieh Sayadi, et al.
Published: (2020-06-01)

Transmission Electron Microscopy of XDR Mycobacterium tuberculosis Isolates Grown on High Dose of Oﬂoxacin
by: Mohammad Arjomandzadegan, et al.
Published: (2017-02-01)

Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution
by: Ximena Gonzalo, et al.
Published: (2020-08-01)

Whole genome sequencing-based characterization of extensively drug resistant (XDR) strains of Mycobacterium tuberculosis from Pakistan
by: Zahra Hasan, et al.
Published: (2015-01-01)

Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
by: Roshni Mary Prince, et al.
Published: (2023-08-01)

Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing
by: Jun Chen, et al.
Published: (2017-04-01)

Machine Learning Predicts Accurately Mycobacterium tuberculosis Drug Resistance From Whole Genome Sequencing Data
by: Wouter Deelder, et al.
Published: (2019-09-01)

Clonal Expansion of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, Japan
by: Yoshiro Murase, et al.
Published: (2010-06-01)

Turning the tide against tuberculosis
by: Nesri Padayatchi, et al.
Published: (2017-03-01)

COVID-19 in Patients with Active Tuberculosis
by: Monika Kozińska, et al.
Published: (2021-09-01)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)

Situación de la tuberculosis en el Perú
by: Cesar Bonilla Asalde
Published: (2020-08-01)

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
by: Viola Dreyer, et al.
Published: (2022-08-01)

Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production
by: Hafij Al Mahmud, et al.
Published: (2017-05-01)

Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
by: Benoît Henry, et al.
Published: (2016-03-01)

Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana
by: Tuelo Mogashoa, et al.
Published: (2019-10-01)

Next-Generation TB Vaccines: Progress, Challenges, and Prospects
by: Li Zhuang, et al.
Published: (2023-07-01)

Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa
by: Alistair D. Calver, et al.
Published: (2010-02-01)

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019
by: Yousra Kherabi, et al.
Published: (2022-09-01)

Beijing Lineage of MDR Mycobacterium tuberculosis in Bulgaria, 2007–2011
by: Stefan Panaiotov, et al.
Published: (2014-11-01)

Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China
by: Xiaocui Wu, et al.
Published: (2019-11-01)

MDR and Pre-XDR Clinical <i>Mycobacterium tuberculosis</i> Beijing Strains: Assessment of Virulence and Host Cytokine Response in Mice Infectious Model
by: Mikhail V. Fursov, et al.
Published: (2021-08-01)

Spread of Extensively Drug-resistant Tuberculosis
by: Sofía Samper, et al.
Published: (2007-04-01)